Open flow microperfusion: pharmacokinetics of human insulin and insulin detemir in the interstitial fluid of subcutaneous adipose tissue

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 121-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free‐mixed aspart and detemir insulin: an open labeled randomized trial

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 5, 2015-08 ,pp. : 345-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes

By Hompesch Marcus   Ocheltree Scott M.   Wondmagegnehu Eshetu T.   Morrow Linda A.   Kollmeier Alexa P.   Campaigne Barbara N.   Jacober Scott J.  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2679-2687

Informa Healthcare

Access to resources Recommend Favorite

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir

By Peterson Gregory E.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2613-2619

Informa Healthcare

Access to resources Recommend Favorite

Glucose‐lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 554-559

John Wiley & Sons Inc

Access to resources Recommend Favorite